Intas Pharmaceuticals Limited Irinotecan Export Data — India (DGFT 2022–2026)

Name: Intas Pharmaceuticals Limited Irinotecan Export Records India — #1 Exporter, 1,099 Shipments, $14.7M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Irinotecan

India Pharmaceutical Trade Intelligence

$41.1M164 Suppliers111 CountriesHS 30049049

ExportsIndia → GERMANY19.7%India → POLAND10.7%

ImportsAUSTRALIA → India$78.4M FRANCE → India$17.9M

#1 Supplier: INTAS PHARMACEUTICALS #1 Buyer: FRESENIUS KABI

Intas Pharmaceuticals Limited — Irinotecan Exporter #1 | $15.1M Trade Value | TransData Nexus | TransData Nexus

Intas Pharmaceuticals Limited — Irinotecan Exporter Profile

Indian Pharmaceutical Exporter · #1 for Irinotecan · $15.1M export value · DGFT Verified

Intas Pharmaceuticals Limited is the #1 Indian exporter of Irinotecan with $15.1M in export value and 1,099 verified shipments. Intas Pharmaceuticals Limited holds a 35.8% market share in Irinotecan exports across 20 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.

Intas Pharmaceuticals Limited — Irinotecan Export Profile: Buyers & Destinations

Intas Pharmaceuticals Limited Irinotecan export treemap — buyers and destination countries | TransData Nexus

Where Does Intas Pharmaceuticals Limited Export Irinotecan?

Country	Value	Shipments	Share
POLAND	$3.2M	155	29.0%
NETHERLANDS	$2.6M	187	23.5%
UNITED KINGDOM	$1.2M	68	11.0%
ITALY	$682.9K	49	6.2%

Who Are the Top Buyers of Irinotecan from Intas Pharmaceuticals Limited?

Buyer	Country	Value	Orders
ALLOGA FRANCE	NETHERLANDS	$1.4M	50
ACCORD HEALTHCARE POLSKA SP. Z.O.O.	POLAND	$1.3M	65
ACCORD HEALTHCARE POLSKA SP. Z O.O.	POLAND	$1.0M	38
ACCORD UK	UNITED KINGDOM	$908.1K	40
BROCACEF NL : HUB	NETHERLANDS	$744.9K	66
TO THE ORDER	HUNGARY	$576.8K	114
ACCORD HEALTHCARE ITALIA SRL	ITALY	$471.6K	30
ACCORD HEALTHCARE POLSKA SP Z O O	POLAND	$423.4K	28
ACCORD HEALTHCARE PTY LTD	AUSTRALIA	$350.0K	7
ACCORD HEALTHCARE INC	CANADA	$319.4K	7

Intas Pharmaceuticals Limited supplies Irinotecan to 70 buyers globally. The largest buyer is ALLOGA FRANCE (NETHERLANDS), followed by ACCORD HEALTHCARE POLSKA SP. Z.O.O. (POLAND) and ACCORD HEALTHCARE POLSKA SP. Z O.O. (POLAND). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Irinotecan Formulations Does Intas Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
PHARMA DRUGS & MEDI IRINOTECAN INJ,20MG/	$2.0M	101
PHARMA DRUG&MED:IRINOTECAN INJ,20MG/ML,2	$202.7K	8
PHARMA DRUG&MED: IRINOTECAN INJ,20MG/ML,	$183.8K	5
PHARMA DRUGS & MEDI IRINOTECAN 20MG/ML,5	$178.1K	7
PHARMA DRUGS & MEDI IRINOTECAN HCL INJ20	$168.9K	17
PHARMA DRUG&MED:IRINOTECAN HCL INJ20MG/M	$165.1K	11
PHARMA DRUGS MEDI IRINOTECAN INJ 20MG ML 25ML ACCOR FRANCE AS PER INVOICE	$150.9K	4
PH.DRU.& MED.: IRINOTECAN HCL INJECTION	$150.0K	3
PHARMA DRUGS AND MEDI IRINOTAS 100 (20 MG/ML 5ML EACH ML CONTAINS IRINOTECAN HCL TRIHYDRATE 20MG.VLS	$150.0K	3
PHARMA DRUGS AND MEDI IRINOTECAN HYDROCHLORIDE INJ 20MG/ML,5ML AS PER INV	$144.2K	4

Intas Pharmaceuticals Limited exports 604 distinct Irinotecan formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMA DRUGS & MEDI IRINOTECAN INJ,20MG/ with 101 shipments worth $2.0M. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Intas Pharmaceuticals Limited Compare to Nearest Irinotecan Exporters?

Exporters ranked immediately above and below #1 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	INTAS PHARMACEUTICALS LIMITED ★	$14.7M	1,099	20	$13.4K
2	FRESENIUS KABI ONCOLOGY LIMITED	$10.4M	670	24	$15.6K
3	EUGIA PHARMA SPECIALITIES LIMITED	$4.4M	88	10	$50.0K

Intas Pharmaceuticals Limited ranks #1 among 164 Indian Irinotecan exporters. Average shipment value of $13.4K compared to the market average of $228.7K. The closest competitors by value are FRESENIUS KABI ONCOLOGY LIMITED and EUGIA PHARMA SPECIALITIES LIMITED.

Which Indian Ports Ship Irinotecan Exports?

Port	Shipments	% Share
DELHI AIR CARGO ACC (INDEL4)	300	10.3%
SAHAR AIR	296	10.2%
AHEMDABAD AIR ACC (INAMD4)	252	8.7%
MUNDRA SEA (INMUN1)	217	7.5%
SAHAR AIR CARGO ACC (INBOM4)	207	7.1%
DELHI AIR	205	7.1%
AHEMDABAD AIR	205	7.1%
MUNDRA SEA	152	5.2%

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Irinotecan Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)

Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Irinotecan shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 1,120 individual customs records matching Intas Pharmaceuticals Limited exporting Irinotecan, covering 604 formulations to 20 countries via 70 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 111+ countries, 495+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Irinotecan

Irinotecan

Intas Pharmaceuticals Limited — Irinotecan Exporter Profile

Intas Pharmaceuticals Limited — Irinotecan Export Profile: Buyers & Destinations

Where Does Intas Pharmaceuticals Limited Export Irinotecan?

Who Are the Top Buyers of Irinotecan from Intas Pharmaceuticals Limited?

What Is India's Total Irinotecan Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Irinotecan Exports?

How Does Intas Pharmaceuticals Limited Compare to Other Indian Irinotecan Exporters?

What Irinotecan Formulations Does Intas Pharmaceuticals Limited Export?

Regulatory Requirements: Exporting Irinotecan to Key Markets

United Kingdom — MHRA

How Does Intas Pharmaceuticals Limited Compare to Nearest Irinotecan Exporters?

Which Indian Ports Ship Irinotecan Exports?

What Other Oncology Products Does Intas Pharmaceuticals Limited Export?

Irinotecan — Export Intelligence Video

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Irinotecan Exports

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Intas Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Irinotecan Export Data from Intas Pharmaceuticals Limited

Irinotecan Stats

Company Overview

Top Products by Intas Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source